Survivorship after neoadjuvant chemotherapy - Authors' reply

Lancet Oncol. 2022 Mar;23(3):e96. doi: 10.1016/S1470-2045(22)00085-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Humans
  • Neoadjuvant Therapy* / adverse effects
  • Survivorship*